Stefan Engst
- Molecular Biology top 10%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Hepatology top 2%
- Pathology and Forensic Medicine top 5%
- Co-authors
- Frauke BentzienF. Michael YakesAlison JolyPeiwen YuFawn QianJenny TanToshihiro YamaguchiFelix Chu
- Topics
- Metabolism and Genetic Disorders (6 papers)Biochemical and Molecular Research (4 papers)Advanced Nanomaterials in Catalysis (3 papers)
- Partner nations
- United StatesGermanyDenmark
In The Last Decade
Stefan Engst
16 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Molecular Biology 1.1k
- Oncology 688
- Pulmonary and Respiratory Medicine 531
- Hepatology 375
- Pathology and Forensic Medicine 302
Countries citing papers authored by Stefan Engst
This map shows the geographic impact of Stefan Engst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Engst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Engst more than expected).
Fields of papers citing papers by Stefan Engst
This network shows the impact of papers produced by Stefan Engst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Engst. The network helps show where Stefan Engst may publish in the future.
Co-authorship network of co-authors of Stefan Engst
This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Engst. A scholar is included among the top collaborators of Stefan Engst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Engst. Stefan Engst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 98 | |
| 2 | 102 | |
| 3 | 200 | |
| 4 | Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growthbreakdown → | 1036 |
| 5 | 282 | |
| 6 | 9 | |
| 7 | 2 | |
| 8 | 40 | |
| 9 | 28 | |
| 10 | 16 | |
| 11 | 42 | |
| 12 | 27 | |
| 13 | Alpha, beta-dehydrogenation by acyl-CoA dehydrogenases: role of functional groups at the active center. | 3 |
| 14 | 8 | |
| 15 | 63 | |
| 16 | 73 |
About Stefan Engst
Stefan Engst is a scholar working on Clinical Biochemistry, Biochemistry and Hepatology, having authored 16 papers that have together received 2.0k indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (6 papers), Biochemical and Molecular Research (4 papers) and Advanced Nanomaterials in Catalysis (3 papers). The work is most often cited by research in Hepatology (375 citations), Oncology (688 citations) and Clinical Biochemistry (169 citations). Stefan Engst has collaborated with scholars based in United States, Germany and Denmark. Frequent co-authors include Frauke Bentzien, F. Michael Yakes, Alison Joly, Peiwen Yu, Fawn Qian, Jenny Tan, Toshihiro Yamaguchi, Felix Chu, Belinda Cancilla and Yongchang Shi. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.